Literature DB >> 27598359

Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies.

Radhika Gangaraju1, Vishnu V B Reddy1, Marisa B Marques1.   

Abstract

Bone marrow necrosis with subsequent embolization of the fat and necrotic tissues into the systemic circulation causing fat embolism syndrome and multiorgan failure is a rare complication of patients with hemoglobinopathies. The exact etiology of this condition is not known. Because it occurs more often in patients with compound heterozygous conditions than in sickle cell disease, some patients are unaware of their predisposition. The initial symptoms are nonspecific, such as back and/or abdominal pain, fever, and fatigue, which may rapidly progress to respiratory failure and severe neurologic compromise. Common laboratory tests reveal anemia without reticulocytosis, thrombocytopenia, leukoerythroblastic picture with immature white cells and nucleated red blood cells, increased lactate dehydrogenase, high ferritin, and, sometimes increased creatinine. The diagnosis can be delayed because of an apparent lack of awareness about bone marrow necrosis with fat embolism syndrome, its rarity, and its similarities with other conditions such as thrombotic thrombocytopenic purpura. Although a bone marrow biopsy is diagnostic, waiting for it delays definitive treatment, which appears to be essential for the recovery of end-organ damage, such as neurologic and pulmonary damage. In our experience, either multiple units of red blood cell transfusion or, preferably, red cell exchange initiated promptly, is lifesaving.

Entities:  

Mesh:

Year:  2016        PMID: 27598359     DOI: 10.14423/SMJ.0000000000000520

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Fat Embolism Syndrome in Sickle Cell β-Thalassemia Patient With Osteonecrosis: An Uncommon Presentation in a Young Adult.

Authors:  Vikram Sangani; Mytri Pokal; Mamtha Balla; Ganesh Prasad Merugu; Waleed Khokher; Vijay Gayam; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

2.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

3.  Complete Neurologic Recovery of Cerebral Fat Embolism Syndrome in Sickle Cell Disease.

Authors:  Oluwayomi Oyedeji; Nwabundo Anusim; Mohammad Alkhoujah; Vrushali Dabak; Zaher K Otrock
Journal:  Cureus       Date:  2022-09-13

4.  Fulminant Cerebral Fat Embolism: Case Description and Review of the Literature.

Authors:  Giorgio Berlot; Rossana Bussani; Vennus Shafiei; Nadia Zarrillo
Journal:  Case Rep Crit Care       Date:  2018-07-11

5.  The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care.

Authors:  Durjoy K Shome; Ahmed Jaradat; Ahmed I Mahozi; Ali S Sinan; Ali Ebrahim; Mohammed Alrahim; Mohammad S Ebraheem; Eman J Mansoor; Kameela S Majed; Sheikh A Azeez Pasha
Journal:  Indian J Crit Care Med       Date:  2018-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.